Hemoglobin variability in nondialysis chronic kidney disease: Examining the association with mortality

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 7, 2009, Pages 1176-1182

  Boudville, Neil C ^a   Djurdjev, Ognjenka ^b   Macdougall, Iain C ^c   De Francisco, Angel L M ^d   Deray, Gilbert ^e   Besarab, Anatole ^f   Stevens, Paul E ^g   Walker, Rowan G ^h   Ureña, Pablo ⁱ   Iñigo, Pablo ^j   Minutolo, Roberto ^k   Haviv, Yosef S ^l   Yeates, Karen ^m   Agüera, Marisa L ^c,n   MacRae, Jennifer M ^o   Levin, Adeera ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HENRY FORD HEALTH SYSTEM   (United States)

^g KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^h ROYAL MELBOURNE HOSPITAL   (Australia)

ⁱ Clinique du Landy   (France)

^j HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^k SECOND UNIVERSITY OF NAPLES   (Italy)

^l HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^m QUEEN S UNIVERSITY   (Canada)

ⁿ Hospital Univeritario Reina Sofia   (Spain)

^o FOOTHILLS HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIANEMIC AGENT; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; AUSTRALIA; BLOOD ANALYSIS; CANADA; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRANCE; GLOMERULUS FILTRATION RATE; HUMAN; ISRAEL; ITALY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; RISK ASSESSMENT; SPAIN; SURVIVAL RATE; TREATMENT DURATION; UNITED KINGDOM; BLOOD; CHRONIC KIDNEY FAILURE; FOLLOW UP; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTION AND FORECASTING; STATISTICAL MODEL; SURVIVAL;

AGED; AGED, 80 AND OVER; ANEMIA; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY, CHRONIC; SURVIVAL ANALYSIS;

EID: 70349324226     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04920908     Document Type: Article

References (16)

1. Lacson E Jr, Ofsthun N, Lazarus JM: Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis 41: 111-124, 2003
2. Berns JS, Elzein H, Lynn RI, Fishbane S, Meisels IS, Deoreo PB: Hemoglobin variability in epoetin-treated hemodialysis patients. Kidney Int 64: 1514-1521, 2003
3. Fishbane S, Berns JS: Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68: 1337-1343, 2005
4. Ebben JP, Gilbertson DT, Foley RN, Collins AJ: Hemoglobin level variability: Associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 1: 1205-1210, 2006
5. Collins AJ, Brenner RM, Ofman JJ, Chi EM, Stuccio-White N, Krishnan M, Solid C, Ofsthun NJ, Lazarus JM: Epoetin alfa use in patients with ESRD: An analysis of recent US prescribing patterns and hemoglobin outcomes. Am J Kidney Dis 46: 481-488, 2005
6. Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ: Hemoglobin level variability: Associations with mortality. Clin J Am Soc Nephrol 3: 133-138, 2008
7. Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K: Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 17: 1181-1191, 2006
8. Yang W, Israni RK, Brunelli SM, Joffe MM, Fishbane S, Feldman HI: Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol 18: 3164-3170, 2007
9. Brunelli SM, Joffe MM, Israni RK, Yang W, Fishbane S, Berns JS, Feldman, HI: History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol 3: 777-782, 2008
10. Walker R, Pussell BA: Fluctuations in haemoglobin levels in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa. Nephrology (Carlton) 12: 448-451, 2007
11. Fishbane S: What is needed to achieve a hemoglobin of 11.0 -13.0 g/dl in end-stage renal disease. Blood Purif 25: 53-57, 2007
12. West RM, Harris K, Gilthorpe MS, Tolman C, Will EJ: Functional data analysis applied to a randomized controlled clinical trial in hemodialysis patients describes the variability of patient responses in the control of renal anemia. J Am Soc Nephrol 18: 2371-2376, 2007
13. Ross DW, Ayscue LH, Watson J, Bentley SA: Stability of hematologic parameters in healthy subjects: Intraindividual versus interindividual variation. Am J Clin Pathol 90: 262-267, 1988
14. Statland BE, Winkel P, Harris SC, Burdsall MJ, Saunders AM: Evaluation of biologic sources of variation of leukocyte counts and other hematologic quantities using very precise automated analyzers. Am J Clin Pathol 69: 48-54, 1978
15. Dot D, Miro J, Fuentes-Arderiu X: Within-subject biological variation of hematological quantities and analytical goals. Arch Pathol Lab Med 116: 825-826, 1992
16. Brigden ML, Heathcote JC: Problems in interpreting laboratory tests: What do unexpected results mean? Postgrad Med 107: 145-146, 151-152, 155-158 passim, 2000